Procise DX is an advanced point-of-care (POC) diagnostic analyzer designed to deliver rapid, laboratory-quality results directly at the patient site. Utilizing innovative fluorescence-based immunoassay technology (TR-FRET), it enables highly sensitive and quantitative testing for biomarkers such as CRP, infliximab, and adalimumab. The system supports finger-prick, serum, or plasma samples and provides results in as little as 2–5 minutes, making it ideal for real-time clinical decision-making. With minimal sample preparation and user-friendly operation, Procise DX enhances workflow efficiency in primary care and hospital settings.